Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-18,766
Closed -$187K 191
2023
Q2
$187K Sell
18,766
-1,166
-6% -$11.1K 0.3% 169
2023
Q1
$192K Buy
19,932
+208
+1% +$2.31K 0.23% 195
2022
Q4
$220K Sell
19,724
-6,821
-26% -$71.3K 0.25% 179
2022
Q3
$226K Buy
+26,545
New +$261K 0.26% 174
2022
Q2
Sell
-31,186
Closed -$339K 500
2022
Q1
$339K Buy
31,186
+10,991
+54% +$145K 0.25% 146
2021
Q4
$273K Buy
+20,195
New +$270K 0.29% 134

Other funds holding VTRS

Delphia (USA)'s VTRS Position: Q3 2023 in Review

Delphia (USA) sold out of Viatris (VTRS) in Q3 2023, closing a stake of 18,766 shares — an estimated $187K sold.

Delphia (USA) first reported a position in VTRS in Q4 2021 and held it in 6 quarters. The position peaked at $339K in Q1 2022. 961 funds tracked by Wall St. Rank hold VTRS as of Q3 2023.

  • Delphia (USA) reported no remaining Viatris position as of Q3 2023 after selling out during the quarter.
  • Delphia (USA) sold 18,766 Viatris shares in Q3 2023, an estimated $187K.
  • Delphia (USA) first reported a position in Viatris in Q4 2021 and held it in 6 quarters.
  • Delphia (USA)'s Viatris position peaked at $339K in Q1 2022.
  • 961 funds tracked by Wall St. Rank held Viatris as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.